Terms: = Germ cell tumor AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Treatment
50 results:
1. Polymer-Drug Conjugates Codeliver a Temozolomide Intermediate and Nitric Oxide for Enhanced Chemotherapy against Glioblastoma Multiforme.
Du K; Li X; Feng F
ACS Appl Bio Mater; 2024 Mar; 7(3):1810-1819. PubMed ID: 38403964
[TBL] [Abstract] [Full Text] [Related]
2. Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM.
Placke JM; Kimmig M; Griewank K; Herbst R; Terheyden P; Utikal J; Pföhler C; Ulrich J; Kreuter A; Mohr P; Gutzmer R; Meier F; Dippel E; Welzel J; Engel DR; Kreft S; Sucker A; Lodde G; Krefting F; Stoffels I; Klode J; Roesch A; Zimmer L; Livingstone E; Hadaschik E; Becker JC; Weichenthal M; Tasdogan A; Schadendorf D; Ugurel S
EBioMedicine; 2023 Oct; 96():104774. PubMed ID: 37660535
[TBL] [Abstract] [Full Text] [Related]
3. A novel peptide P1-121aa encoded by STK24P1 regulates vasculogenic mimicry via ELF2 phosphorylation in glioblastoma.
Li T; Liu X; Ruan X; Dong W; Liu Y; Wang P; Liu L; Tiange E; Song J; Pan A; Xue Y
Exp Neurol; 2023 Sep; 367():114477. PubMed ID: 37406957
[TBL] [Abstract] [Full Text] [Related]
4. Advancements in super-selective catheterization and drug selection for intra-arterial chemotherapy for retinoblastoma: a 15-year evolution.
Kocharian G; Gobin YP; Kharas N; Knopman J; Francis JH; Abramson DH
J Neurointerv Surg; 2024 Mar; 16(4):398-404. PubMed ID: 37197934
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas.
Scholl JN; Weber AF; Dias CK; Lima VP; Grun LK; Zambonin D; Anzolin E; Dos Santos Dias WW; Kus WP; Barbé-Tuana F; Battastini AMO; Worm PV; Figueiró F
Purinergic Signal; 2024 Feb; 20(1):47-64. PubMed ID: 36964277
[TBL] [Abstract] [Full Text] [Related]
6. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
[TBL] [Abstract] [Full Text] [Related]
7. In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma.
Jeising S; Geerling G; Guthoff R; Hänggi D; Sabel M; Rapp M; Nickel AC
Photodiagnosis Photodyn Ther; 2022 Dec; 40():103049. PubMed ID: 35932958
[TBL] [Abstract] [Full Text] [Related]
8. Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma.
Coleman S; Xie M; Tarhini AA; Tan AC
Mol Carcinog; 2023 Jan; 62(1):77-89. PubMed ID: 35781709
[TBL] [Abstract] [Full Text] [Related]
9. Personalized functional profiling using
Kim H; El-Khoury V; Schulte N; Zhan T; Betge J; Cousin L; Felli E; Pessaux P; Ogier A; Opitz O; Ku B; Ebert MP; Kwon YJ
Cancer Biol Ther; 2022 Dec; 23(1):96-102. PubMed ID: 35193475
[TBL] [Abstract] [Full Text] [Related]
10. Multifunctional liposome for photoacoustic/ultrasound imaging-guided chemo/photothermal retinoblastoma therapy.
Li M; Bian X; Chen X; Fan N; Zou H; Bao Y; Zhou Y
Drug Deliv; 2022 Dec; 29(1):519-533. PubMed ID: 35156504
[TBL] [Abstract] [Full Text] [Related]
11. Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial.
Krug S; Kegel T; Gress TM; Rinke A; Apostolidis L; Jann H; König A; Hörsch D; Schrader J; Ettrich TJ; Richter M; Steighardt J; Michl P
BMC Cancer; 2021 Nov; 21(1):1206. PubMed ID: 34772353
[TBL] [Abstract] [Full Text] [Related]
12. Glioma escape signature and clonal development under immune pressure.
Maire CL; Mohme M; Bockmayr M; Fita KD; Riecken K; Börnigen D; Alawi M; Failla A; Kolbe K; Zapf S; Holz M; Neumann K; Dührsen L; Lange T; Fehse B; Westphal M; Lamszus K
J Clin Invest; 2020 Oct; 130(10):5257-5271. PubMed ID: 32603315
[TBL] [Abstract] [Full Text] [Related]
13. Multifunctional Nanoparticles for Multimodal Imaging-Guided Low-Intensity Focused Ultrasound/Immunosynergistic Retinoblastoma Therapy.
Wang M; Yang Q; Li M; Zou H; Wang Z; Ran H; Zheng Y; Jian J; Zhou Y; Luo Y; Ran Y; Jiang S; Zhou X
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5642-5657. PubMed ID: 31940169
[TBL] [Abstract] [Full Text] [Related]
14. A Triple-Classification Radiomics Model for the Differentiation of Primary Chordoma, Giant cell tumor, and Metastatic tumor of Sacrum Based on T2-Weighted and Contrast-Enhanced T1-Weighted MRI.
Yin P; Mao N; Zhao C; Wu J; Chen L; Hong N
J Magn Reson Imaging; 2019 Mar; 49(3):752-759. PubMed ID: 30430686
[TBL] [Abstract] [Full Text] [Related]
15. RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastoma.
Bagley SJ; Hwang WT; Brem S; Linette GP; O'Rourke DM; Desai AS
J Neurooncol; 2019 Jan; 141(1):95-102. PubMed ID: 30353265
[TBL] [Abstract] [Full Text] [Related]
16. Prediction of time-integrated activity coefficients in PRRT using simulated dynamic PET and a pharmacokinetic model.
Hardiansyah D; Attarwala AA; Kletting P; Mottaghy FM; Glatting G
Phys Med; 2017 Oct; 42():298-304. PubMed ID: 28739143
[TBL] [Abstract] [Full Text] [Related]
17. The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis.
De Luca A; Carpanese D; Rapanotti MC; Viguria TM; Forgione MA; Rotili D; Fulci C; Iorio E; Quintieri L; Chimenti S; Bianchi L; Rosato A; Caccuri AM
Oncotarget; 2017 Feb; 8(9):15520-15538. PubMed ID: 28107182
[TBL] [Abstract] [Full Text] [Related]
18. Valproic Acid Increases CD133 Positive cells that Show Low Sensitivity to Cytostatics in Neuroblastoma.
Khalil MA; Hraběta J; Groh T; Procházka P; Doktorová H; Eckschlager T
PLoS One; 2016; 11(9):e0162916. PubMed ID: 27627801
[TBL] [Abstract] [Full Text] [Related]
19. Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits.
Calvani M; Bianchini F; Taddei ML; Becatti M; Giannoni E; Chiarugi P; Calorini L
Oncotarget; 2016 Aug; 7(32):51138-51149. PubMed ID: 27303923
[TBL] [Abstract] [Full Text] [Related]
20. A tumor-suppressive microRNA, miR-504, inhibits cell proliferation and promotes apoptosis by targeting FOXP1 in human glioma.
Cui R; Guan Y; Sun C; Chen L; Bao Y; Li G; Qiu B; Meng X; Pang C; Wang Y
Cancer Lett; 2016 Apr; 374(1):1-11. PubMed ID: 26854715
[TBL] [Abstract] [Full Text] [Related]
[Next]